LONDON, 9-10-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE: GSK) today announced the appointment of Mr Urs Rohner to its Board as a Non-Executive Director, effective 1 January 2015. On appointment, Mr Rohner will also become a member of GSK’s Remuneration Committee.
Mr Rohner is currently Chairman of Credit Suisse Group AG, one of the world’s leading financial services companies.
Commenting on the appointment, Sir Christopher Gent, Chairman of GSK, said: “I am delighted to welcome Urs to the Board. His broad business background and extensive senior-level experience at multinational companies makes him a great addition to GSK.”
Mr Rohner was appointed Chairman of Credit Suisse in 2011 following a number of senior positions at the company including General Counsel and Chief Operating Officer. Before joining Credit Suisse in 2004, he was Chief Executive Officer and Chairman for four years at ProSiebenSat.1 Group, one of the largest independent media corporations in Europe. This followed a number of years in private practice at major law firms in Switzerland and the USA.
Victoria Whyte
Company Secretary
Notes
Contact info
(IN BRIEF) Airbus has announced the launch of the Pléiades Neo Next program, aimed at…
(IN BRIEF) DeLaval, a Swedish-based dairy and farming machinery producer under the Tetra Laval Group,…
(IN BRIEF) BevZero, a global leader in beverage innovation, takes a significant step towards sustainability…
(IN BRIEF) The Lenzing Group announces the Lenzing Young Scientist Award at the Dornbirn Global…
(IN BRIEF) Josée Ouellet, Vice President of Services for Alstom in North America, has been…
(IN BRIEF) Alstom was honored with the 2024 Hydrogen Mobility Award at the 2024 Canadian…